作者: Koji Tamada , Eduardo Davila
DOI:
关键词: Antigen presentation 、 Cytotoxic T cell 、 IL-2 receptor 、 T cell 、 Streptamer 、 Biology 、 Interleukin 21 、 Cancer research 、 Antigen 、 Antigen-presenting cell 、 Molecular biology
摘要: The present invention provides a universal, yet adaptable, anti-tag chimeric antigen receptor (AT-CAR) system which T cells with the ability and specificity to recognize kill target cells, such as tumor that have been marked by tagged antibodies. As an example, αFITC-CAR-expressing developed specifically various human cancer when those are bound cancer-reactive FITC-labeled activation of is shown induce efficient lysis, cell proliferation, cytokine/chemokine production. can be used treating subjects having cancer.